Robert Leo Walker Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1400 Hospital Dr, Hurricane, WV 25526 Phone: 304-720-8816 Fax: 904-494-6467 |
Dr. Amanda Lee Deskins, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1400 Hospital Dr, Hurricane, WV 25526 Phone: 304-720-8816 Fax: 904-494-6467 |
Kenneth F Mcneil, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Hospital Dr, Hurricane, WV 25526 Phone: 304-720-8816 Fax: 904-494-6467 |
Jonathan David Estes, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 50 Doral St, Hurricane, WV 25526 Phone: 304-760-8183 |
John Dylan Davis, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1400 Hospital Dr, Hurricane, WV 25526 Phone: 304-720-8816 Fax: 904-494-6467 |
News Archive
The offspring of women who were given micronutrient supplements (minerals needed in small quantities, such as iron, iodine and vitamin A) before they became pregnant had gene modifications at birth as well as when they were tested at 9 months.
Findings from a new poll indicate that the public felt less favorable about both the health law and the Supreme Court after last week's oral arguments.
Research by a team of investigators in Finland suggests that the free recall memory deficits common even in early stages Parkinson's disease are related to structural changes in the brain, specifically parietal cortical gray matter volume. Their findings are published in the current issue of the Journal of Parkinson's Disease.
About 3.4 million people, or 13.9 percent of the population age 71 and older, have some form of dementia, the study found. As expected, the prevalence of dementia increased dramatically with age, from five percent of those aged 71 to 79 to 37.4 percent of those age 90 and older.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 4 days ago